Latigo Biotherapeutics
ID: 16396779Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.
1
Funding Rounds
$150.0m
Money raised
Recent Funding Rounds
Overview
Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.
- Website:
- Business model: B2B
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding series
Funding Series Analysis
The company Latigo Biotherapeutics has raised a total of $150m in funding over 1 rounds.
Key Insights:
- Latigo Biotherapeutics March 2025 Series B Funding Round: $150m
Industries
Latigo Biotherapeutics is active in the following industries: